LLY80 Stock Price and Chart — SET:LLY80 — TradingView

Compare with Eli Lilly & Co Units Thailand Depositery Receipts Repr 0.01 Sh

Key facts today

Eli Lilly says retatrutide showed positive TRIUMPH‑2 and TRIUMPH‑3 results and plans an FDA submission in Q1 2027 after providing additional manufacturing and quality‑control data.

Analyze the impact Analyze the impact

Key stats

Upcoming earnings

Details

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

Chart Whisperer | Intuitive Market Analysis I don’t look at the markets the way everyone else does. I consider myself a bit of a chart whisperer—not because I have a secret algorithm, but because years of staring at the screens have given me a deeply personal, intuitive feel for price action. My trading style is anchored in reading the natura

Could this be E-Lie Lilly? Institutions Just Showed Their Hand!There's an old saying we have in the South..."A lie doesn't care who tells it." That just simply means that when a lie wants to get out and be believed as truth, it doesn't care what method is used to accomplish that. Over the years, I've made my own addition to that..."A lie doesn't care who tell

by AkeelahTraders

ELI LILLY Strong RSI Bearish Divergence targets $1000.Eli Lilly (LLY) has been trading within a 14-month Channel Up and is currently on a Higher Highs rejection. The 1D RSI is under Lower Highs however, displaying a technical Bearish Divergence that we last saw within this pattern on the January 08 2026 High. The result of this formation was a Bearish

LLY | Continued stock growth - Timeframe: Weekly - Trade type: Buy stop order - Price: 1,196.29 - Take Profit: Open - Stop Loss: 1,134.40 (-5.20 %) Idea: Long on a breakout above last week's high - bullish momentum continuation. Entry: Buy stop above last week’s high. Stop-loss: Below the low of the same candle. If the weekly

LLY: Buyers Return as Pullback Creates Entry Opportunity LLY is beginning to attract renewed buying interest following its recent retracement. The stock remains in a strong uptrend, continuing to make higher highs and higher lows while trading above well-aligned 20 and 50-day moving averages, signaling that bullish momentum remains intact. Eli Lilly & Co

by finvestnomics

Fake, But Don't Break! Eli Lilly Still Has a Structural Problem Happy Monday, Traders. For the past several day, LLY has been giving Fake-Out After Fake-Out to the upside, looking like its going to tske off again… But the Structure STILL Says DOWN. We have been following Eli Lilly since this H1 Break of Structure DOWN back on 6/29. And since then? This struct

by AkeelahTraders

LLY: Healthy Pullback… Or Bigger Problem Ahead?LLY… Uh Oh… Lilly Looking a Little Sick Here? After a strong bullish run higher, LLY finally gave us something we had not seen in a while: ➡️ An H1 BOS DOWN And more importantly… …the market returned directly back into the H1 BOS Supply Source for the retest. That retest matters. Because once

by AkeelahTraders

LLY: 15-Month Base on Base & 235% Volume Breakout The Setup: Eli Lilly ( NYSE:LLY ) is capitalizing on a massive fundamental double-catalyst—including new broad Medicare coverage for its weight-loss drugs—to trigger an explosive move. The stock has carved out a massive Base-on-Base structure on the monthly chart. After a deliberate retail shakeo

LLY- Breakout Above Persistent Resistance Opens Strong Upside NYSE:LLY shares jumped over 7% on Friday on strong volume after positive regulatory and policy developments. The European Medicines Agency’s Committee for Medicinal Products for Human Use backed its cancer drug Jaypirca, while the company’s popular weight-loss treatments are also expected to be inc

Eli Lilly Rebounds From 20-Day Support as Uptrend Continues LLY is rebounding after retracing to its 20-day moving average, with buyers stepping in to support the trend. The stock remains in a strong uptrend, making higher highs and higher lows while trading above its well-aligned 20- and 50-day moving averages. Eli Lilly & Co. is a $1.14 trillion market-ca

by finvestnomics

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds

Maturity dateSep 14, 2043

Coupon1.63% (Fixed)

Maturity dateMay 20, 2066

Coupon5.70% (Fixed)

Maturity dateAug 14, 2064

Coupon5.20% (Fixed)

Maturity dateOct 15, 2065

Coupon5.65% (Fixed)

Maturity dateFeb 9, 2064

Coupon5.10% (Fixed)

Maturity dateFeb 27, 2063

Coupon4.95% (Fixed)

Maturity dateFeb 12, 2065

Coupon5.60% (Fixed)

Maturity dateMar 15, 2059

Coupon4.15% (Fixed)

Maturity dateFeb 27, 2053

Coupon4.88% (Fixed)

Maturity dateFeb 9, 2054

Coupon5.00% (Fixed)

Maturity dateAug 14, 2054

Coupon5.05% (Fixed)

See all LLY80 bonds